Please assess the completion status of the following clinical trial:

Trial Title: The Effect of Platelet Rich Plasma on Pain at Skin Graft Donor Sites

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Any patient requiring a split thickness skin graft and is above the age of 18.~Exclusion Criteria:~* Medical history of chronic pain at the donor site~* Inability to follow up~* Unable to participate in pre or post operative questionnaire inclusive of organic~* Traumatic, chemical or degenerative causes of altered mental sensorium~* Age \<18.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- PRP (Type: EXPERIMENTAL): Intervention group will receive PRP instead of the standard of care for skin grafts. PRP Group-will remove surgical dressing post operative day 5. Donor site will be cleaned with soap and water daily and dressed with gauze daily until drainage stops.
- Control (Type: NO_INTERVENTION): Control group receiving the standard of care for skin grafts. Control Group-will remove gauze dressing post operative day 2 but leave adeptic. Donor site will be cleaned daily with soap and water. Gauze applied daily as needed for drainage and will be stopped when drainage stops. The adeptic, which forms a biologic dressing, will be removed by the patient over time as it lifts from the wound.

Based on this trial design, predict the completion outcome and termination type (if applicable).